Correlation Between IShares MSCI and GeneThera
Can any of the company-specific risk be diversified away by investing in both IShares MSCI and GeneThera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares MSCI and GeneThera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares MSCI and GeneThera, you can compare the effects of market volatilities on IShares MSCI and GeneThera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares MSCI with a short position of GeneThera. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares MSCI and GeneThera.
Diversification Opportunities for IShares MSCI and GeneThera
1.0 | Correlation Coefficient |
No risk reduction
The 3 months correlation between IShares and GeneThera is 1.0. Overlapping area represents the amount of risk that can be diversified away by holding iShares MSCI and GeneThera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneThera and IShares MSCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares MSCI are associated (or correlated) with GeneThera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneThera has no effect on the direction of IShares MSCI i.e., IShares MSCI and GeneThera go up and down completely randomly.
Pair Corralation between IShares MSCI and GeneThera
If you would invest 0.01 in GeneThera on September 2, 2024 and sell it today you would earn a total of 0.00 from holding GeneThera or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 95.45% |
Values | Daily Returns |
iShares MSCI vs. GeneThera
Performance |
Timeline |
iShares MSCI |
GeneThera |
IShares MSCI and GeneThera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with IShares MSCI and GeneThera
The main advantage of trading using opposite IShares MSCI and GeneThera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares MSCI position performs unexpectedly, GeneThera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will offset losses from the drop in GeneThera's long position.IShares MSCI vs. Legacy Education | IShares MSCI vs. Apple Inc | IShares MSCI vs. NVIDIA | IShares MSCI vs. Microsoft |
GeneThera vs. Rigel Pharmaceuticals | GeneThera vs. Geron | GeneThera vs. Verastem | GeneThera vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |